Unity Biotechnology's total assets for Q3 2024 were $47.13M, a decrease of -11.94% from the previous quarter. UBX total liabilities were $32.99M for the fiscal quarter, a -2.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.